What question did this study set out to answer?

The aim is to update the understanding of microbiological quality and compliance issues in non-sterile drug manufacturing.

Non-sterile Drug Products - Microbiologically Related Recalls and Compliance Issues

View Full Paper

Ask AI

Bookmark

Authors

This review provides an update on microbiological risks and compliance issues in non-sterile drugs, highlighting necessary improvements.

The aim is to update the understanding of microbiological quality and compliance issues in non-sterile drug manufacturing.
Review of drug recalls and Form FDA 483s
Analysis of microbiological quality incidences
Examination of compliance shortfalls from previous publications.
Increased incidents of non-sterile product recalls observed from 2004 to 2019
Detailed abundance analysis indicates prevalent microbiological quality issues
Identified specific microorganisms responsible for compliance failures.

Edward C. Tidswell (2026) studied this question.

View Full Paper

Ask AI

Bookmark